Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aurisco Pharmaceutical CoSHSE:605116 -1.88%78 Dividend Yield % is 1.81% as of Jul. 25, 2026, which is 132% above its 10-year median of 0.78. GuruFocus rates SHSE:605116 with a GF Score™ of 78/100 and a GF Value™ of ¥28.92 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 151 Biotechnology companies, Aurisco Pharmaceutical Co ranks better than 59.6% on this metric.
During the past 12 months, Aurisco Pharmaceutical Co's average Dividends Per Share Growth Rate was 31.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 30.70% per year.
During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Aurisco Pharmaceutical Co was 30.70% per year. The lowest was 22.40% per year. And the median was 26.55% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Aurisco Pharmaceutical Co (SHSE:605116) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:605116 vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, Aurisco Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurisco Pharmaceutical Co Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aurisco Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Aurisco Pharmaceutical Co's Dividend Yield % falls into.
Aurisco Pharmaceutical Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Aurisco Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.340000
2026-06-15
2026-06-12
2026-06-15
Cash Dividend
annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurisco Pharmaceutical Co (SHSE:605116) has a Dividend Yield % of 1.81% as of Jul. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Aurisco Pharmaceutical Co and its competitors. This is 132% above median its historical median of 0.78. Over the past decade, Aurisco Pharmaceutical Co's Dividend Yield % has ranged from 0.45 to 1.81. According to the industry distribution chart, Aurisco Pharmaceutical Co ranks #61 out of 151 companies in the Biotechnology industry, placing it in the top 40.4%.
Is Aurisco Pharmaceutical Co's Dividend Yield % too high?
Aurisco Pharmaceutical Co's current Dividend Yield % of 1.81% is 132% above median its 10-year median of 0.78. Over the past 10 years, this metric has ranged from a low of 0.45 to a high of 1.81. The Biotechnology industry median Dividend Yield % is 1.32. Aurisco Pharmaceutical Co's value of 1.81% is 37.1% above this industry median. Based on the distribution chart, Aurisco Pharmaceutical Co ranks #61 out of 151 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Aurisco Pharmaceutical Co has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aurisco Pharmaceutical Co's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aurisco Pharmaceutical Co ranks #61 out of 151 companies for Dividend Yield %. This puts Aurisco Pharmaceutical Co in the upper half of its industry. The industry median Dividend Yield % is 1.32. Aurisco Pharmaceutical Co's value of 1.81% is 37.1% above this benchmark. Historically, Aurisco Pharmaceutical Co's own Dividend Yield % has ranged from 0.45 to 1.81 over the past decade. While the company's 10-year median is 0.78 vs. the industry median of 1.32, Aurisco Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.32, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aurisco Pharmaceutical Co's current Dividend Yield % of 1.81% is 37.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Aurisco Pharmaceutical Co and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurisco Pharmaceutical Co's current Dividend Yield % is 1.81%, which is 132% above median its own 10-year median of 0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurisco Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Aurisco Pharmaceutical Co (SHSE:605116) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥28.92, compared to a current price of ¥18.74 — trading 35.2% below its estimated fair value. The current Dividend Yield % is 1.81%, which is 132% above median its 10-year median of 0.78 and 37.1% above the Biotechnology industry median of 1.32. Aurisco Pharmaceutical Co's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Aurisco Pharmaceutical Co (SHSE:605116), the current Dividend Yield % is 1.81% as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurisco Pharmaceutical Co (SHSE:605116) Overvalued in 2026?
Based on GuruFocus' analysis, Aurisco Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥18.74 is trading 35.2% below its estimated GF Value™ of ¥28.92.
GuruFocus considers Aurisco Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for SHSE:605116:
Dividend Yield %: 1.81% (132% above median its 10-year median of 0.78)
GF Value™: ¥28.92 vs. price of ¥18.74 (35.2% below fair value)
Industry Position: 37.1% above the Biotechnology median (#61 of 151)
No single metric tells the full story. See the SHSE:605116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurisco Pharmaceutical Co Ltd is engaged in production and sales of specialty APIs and pharmaceutical intermediates. The company's products include API's and Intermediates. Its products are supplied to Asia, Europe, America and Middle East through a well-established sales network.
78GF Score
Get the complete analysis for SHSE:605116
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605116 has been successfully added to your 
